Pliant Therapeutics director Flavia Borellini files initial beneficial ownership statement
PLRX•Initial Form 3 filing
- Pliant Therapeutics director Flavia Borellini filed an initial Form 3 statement on July 9.
Related News
Dollar edges higher on escalating US-Iran tension, yen slides on pension doubts
SPY•
Walmart must face gay ex-worker's harassment claim, US court rules
WMT•
Weatherford announces special shareholder meetings on proposed redomestication
WFRD•
Brera Holdings names Erez Simha board chairman
BREA•
Trump says US attacking Iran capabilities related to Strait of Hormuz
XLE•